Tag: biology

November 8, 2022
Dr. Lucy Abgaryan: Finding Treatments for Myotonic Dystrophy

Dr. Lucy Abgaryan: Finding Treatments for Myotonic Dystrophy

Dr. Lucy Abgaryan, the co-founder and CEO of GrittGene Therapeutics, a biotech company based in Los Angeles, California, joins us to discuss how her company is working to find treatments for Myotonic Dystrophy, a rare genetic disorder that causes progressive muscle loss and weakness. Lucy also shared with us her experience in trying to find opportunities to work with the local Armenian biotech industry.

October 18, 2022
Ashot Papoyan and Haig Eskandarian: Biotech and Experimental Biology

Ashot Papoyan and Haig Eskandarian: Biotech and Experimental Biology

This week on EVN Disrupt we are continuing our series of podcasts from the Science and Technology Convergence Conference. Once again, we have two guests on this week’s podcast. Our first guest is Ashot Papoyan, a biotech executive who is the Chief Operating Officer at Biosim and CEO of Elm Tree Research. Our second guest is Haig Eskandarian, a microbiologist at the University of California, San Francisco. With our two guests we spoke about experimental biology and commercializing science findings in the biotech industry.

August 23, 2022

Zareh Zurabyan: Understanding the Biotech Ecosystem

Zareh Zurabyan, the head of the Americas division at eLabNext, a European biotech company, joins us to discuss problems the biotech industry is currently working to solve. Zareh describes who the different players in biotech ecosystems are and what trends he is seeing in the industry in 2022. We also discussed his efforts to mentor Armenian start-ups and his thoughts on Armenia’s biotech scene.

April 12, 2022

Lilit Nersisyan: At the Intersection of Biology and Tech

This week on EVN Disrupt, Lilit Nersisyan, a bioinformatician and the founder of the Armenian Bioinformatics Institute (ABI), joins us to discuss the field of bioinformatics, its role in the world today, and what ABI is working on. We also discussed science commercialization, and the biotech industry.